HARBOR CAPITAL ADVISORS, INC. - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 15 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.9%.

Quarter-by-quarter ownership
HARBOR CAPITAL ADVISORS, INC. ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q1 2023$49,556
-22.9%
107,731
-16.6%
0.01%
-77.4%
Q4 2022$64,313
-30.1%
129,169
-2.1%
0.06%
-26.2%
Q3 2022$92,000
-28.7%
131,957
-10.0%
0.08%
-14.3%
Q2 2022$129,000
-20.4%
146,562
+1.3%
0.10%
+28.9%
Q1 2022$162,000
-55.0%
144,672
-20.7%
0.08%
-42.0%
Q4 2021$360,000182,5210.13%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q3 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 1,379,843$11,246,0002.62%
Novo Holdings A/S 2,361,229$19,244,0000.85%
Ally Bridge Group (NY) LLC 401,747$3,274,0000.81%
SECTORAL ASSET MANAGEMENT INC 640,714$5,222,0000.42%
FRAZIER MANAGEMENT LLC 550,000$4,483,0000.41%
TFG Asset Management GP Ltd 750,000$6,113,0000.33%
Eventide Asset Management 2,485,656$19,757,0000.26%
AXA S.A. 1,111,510$9,058,0000.01%
Woodline Partners LP 25,932$211,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 2,001,951$16,315,0000.00%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders